gefitinib has been researched along with beta-elemene in 3 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (beta-elemene) | Trials (beta-elemene) | Recent Studies (post-2010) (beta-elemene) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 258 | 1 | 211 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Mu, L; Tang, X; Wang, T; Yuan, Y; Zhao, Y | 1 |
| Chen, X; Han, X; Jin, T; Li, G; Li, Q; Liu, S; Lv, Q; Pan, T; Sui, X; Wang, J; Xie, T; Yan, L; Zhang, M; Zhang, Q; Zhuo, L | 1 |
| Dai, P; Han, W; Li, J; Li, K; Sun, J; Yu, W | 1 |
3 other study(ies) available for gefitinib and beta-elemene
| Article | Year |
|---|---|
β-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Quinazolines; Sesquiterpenes; Signal Transduction | 2016 |
The mechanism of m
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Female; Gefitinib; Humans; Lung Neoplasms; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Molecular; Random Allocation; Sesquiterpenes; Xenograft Model Antitumor Assays | 2020 |
FBP1 induced by β-elemene enhances the sensitivity of gefitinib in lung cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Gefitinib; Humans; Lung Neoplasms; Mice; Mice, Nude | 2023 |